NAV

Iodamide

Identification

Generic Name
Iodamide
DrugBank Accession Number
DB08948
Background

Iodamide is a contrast medium molecule that is no longer marketed in the United States.

Type
Small Molecule
Groups
Withdrawn
Structure
 3D
Similar Structures
Weight
Average: 627.9402
Monoisotopic: 627.78528711
Chemical Formula
C12H11I3N2O4
Synonyms
  • Ametriiodic acid
  • Ametriiodinic acid
  • Ametriodinic acid
  • Iodamida
  • Iodamide
  • Iodamidum
  • Urombrine
External IDs
  • B 4130
  • B-4130
  • SH 926
  • SH-926

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug events
Improve clinical decision support with information oncontraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including:blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRsBrowse all" title="" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
Not Available

Interactions

Drug InteractionsLearn More" title="" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Product Ingredients
Ingredient UNII CAS InChI Key
Iodamide meglumine 6X283535A3 18656-21-8 UYIPQECISAQMIU-WZTVWXICSA-N
International/Other Brands
Angiomiron (Schering)/Jodomiron/Renovue/Uromiro/Uromiron (Schering)

Categories

ATC Codes
V08AA03 — Iodamide
Drug Categories
Chemical TaxonomyProvided byClassyfire
Description
This compound belongs to the class of organic compounds known as halobenzoic acids. These are benzoic acids carrying a halogen atom on the benzene ring.
Kingdom
Organic compounds
Super Class
Benzenoids
Class
Benzene and substituted derivatives
Sub Class
Benzoic acids and derivatives
Direct Parent
Halobenzoic acids
Alternative Parents
2-halobenzoic acids/4-halobenzoic acids/Benzoic acids/1-carboxy-2-haloaromatic compounds/Benzoyl derivatives/Iodobenzenes/Aryl iodides/Vinylogous halides/Monocarboxylic acids and derivatives/Carboximidic acids
show 7 more
Substituents
1-carboxy-2-haloaromatic compound/2-halobenzoic acid/2-halobenzoic acid or derivatives/4-halobenzoic acid/4-halobenzoic acid or derivatives/Aromatic homomonocyclic compound/Aryl halide/Aryl iodide/Benzoic acid/Benzoyl
show 20 more
Molecular Framework
Aromatic homomonocyclic compounds
External Descriptors
organoiodine compound, benzoic acids (CHEBI:31703)
Affected organisms
Not Available

Chemical Identifiers

UNII
4RII332O0R
CAS number
440-58-4
InChI Key
VVDGWALACJEJKG-UHFFFAOYSA-N
InChI
InChI=1S/C12H11I3N2O4/c1-4(18)16-3-6-8(13)7(12(20)21)10(15)11(9(6)14)17-5(2)19/h3H2,1-2H3,(H,16,18)(H,17,19)(H,20,21)
IUPAC Name
3-acetamido-5-(acetamidomethyl)-2,4,6-triiodobenzoic acid
SMILES
CC(=O)NCC1=C(I)C(NC(C)=O)=C(I)C(C(O)=O)=C1I

References

General References
Not Available
KEGG Drug
D01376
PubChem Compound
3723
PubChem Substance
310264914
ChemSpider
3592
RxNav
5928
ChEBI
31703
ChEMBL
CHEMBL1201239
ZINC
ZINC000003830933
Drugs.com
Drugs.com Drug Page
Wikipedia
Iodamide

Clinical Trials

Clinical TrialsLearn More" title="" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
Phase Status Purpose Conditions Count

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Form Route Strength
Solution Intravesical
Injection, solution Intravenous
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
Property Value Source
Water Solubility 0.0577 mg/mL ALOGPS
logP 2.55 ALOGPS
logP 2.6 ChemAxon
logS -4 ALOGPS
pKa (Strongest Acidic) 2.28 ChemAxon
pKa (Strongest Basic) -1.8 ChemAxon
Physiological Charge -1 ChemAxon
Hydrogen Acceptor Count 4 ChemAxon
Hydrogen Donor Count 3 ChemAxon
Polar Surface Area 95.5 Å2 ChemAxon
Rotatable Bond Count 4 ChemAxon
Refractivity 106.18 m3·mol-1 ChemAxon
Polarizability 40.78 Å3 ChemAxon
Number of Rings 1 ChemAxon
Bioavailability 1 ChemAxon
Rule of Five No ChemAxon
Ghose Filter No ChemAxon
Veber's Rule No ChemAxon
MDDR-like Rule No ChemAxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Spectrum Spectrum Type Splash Key
Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available
Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available
Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available
Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available
Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available
Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available

Drug created at May 27, 2014 17:35 / Updated at February 21, 2021 18:52